Home » Newsletters » BioWorld Science

BioWorld Science

April 20, 2000

View Archived Issues

Pharmacokinetics of SAM-486A useful in predicting toxicity

Positive preclinical results reported for Meditech's MTCH-24

Aurora Biosciences and Organon sign assay development agreement

Expired air from asthmatic subjects has unusually low pH

Initial clinical results with HE-2000 indicate immune system switch in HIV

Arisostatins identified as new tetrocarcin antibiotics with antibacterial/antitumor activity

Pharming highlights product development efforts for 1999

Clinical progress at Amylin during 1999 discussed

Adefovir dipivoxil shows activity against lamivudine-resistant HBV

Phytopharm invests in Indian manufacturing plant

Glaxo Wellcome obtains nonexclusive HCV license from Chiron

Company Profile: Novuspharma

New 5-HT4 antagonists preferably useful for urinary tract disorders

Antifungal lactone isolated from a fungus at Pfizer

SB's new dopamine D3 receptor modulators particularly useful for schizophrenia

Broad-spectrum carbapenems reported by Wyeth Lederle Japan

BioInvent to produce therapeutic antibody for Wilex

FDA approves Actonel for osteoporosis prevention and treatment

Flocor study results presented at sickle cell conference

BioTime begins clinical testing of new blood plasma volume expander

Major European launch announced for Sonata

Antihistamines reported useful by Schering-Plough for Rx of sinusitis and otitis media

Azabicyclic compounds as modulators of cell adhesion

Florida A&M's novel nonsteroidal antiinflammatory agents inhibit NO production

Preclinical and clinical efficacy of RWJ-270201 characterized at recent congress

FDA approves first oxazolidinone antimicrobial drug

PEG-hirudin superior to unfractionated heparin for short-term reduction of silent ischemia

Health Canada approves Aggrenox for prevention of recurrent stroke

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 9, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins
BioWorld
If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...